{"basic_info": {"ticker": "300363", "exchange": "XSHE", "bloomberg_ticker": "300363 CH Equity", "name": "PORTON PHARMA SOLUTIONS L-A", "industry": "Pharmaceuticals", "name_chinese_simplified": "博腾股份", "period": "2020", "market_value": 19213262848, "total_income": 2071875421, "ccy": "人民币元", "shariah_compliance_summary": "compliant"}, "business_activity_screening": {"summary": [{"shariah_compliance": "compliant", "income": 2013412579, "business_income_over_total_income": 0.9717826460956891}, {"shariah_compliance": "unknown", "income": 58462841, "business_income_over_total_income": 0.028217353421656332}], "details": [{"business_activity_cn": "临床后期及商业化业务", "business_activity_en": "Late-stage clinical and commercial business", "income": 1448945669, "business_income_over_total_income": 0.6993401506257841, "shariah_compliance": "compliant"}, {"business_activity_cn": "临床早期业务", "business_activity_en": "Early clinical services", "income": 564466910, "business_income_over_total_income": 0.272442495469905, "shariah_compliance": "compliant"}, {"business_activity_cn": "其他", "business_activity_en": "other", "income": 58462841, "business_income_over_total_income": 0.028217353421656332, "shariah_compliance": "unknown"}, {"business_activity_cn": "合计特别调整", "business_activity_en": "Total special adjustments", "income": 0, "business_income_over_total_income": 0.0, "shariah_compliance": "unknown"}]}, "financial_screening": [{"item": "Debt to Market Capitalization", "amount": 0.01819958044069565, "shariah_compliance": "compliant", "amount_over_market_value": 0.01819958044069565}]}